{
  "paper_metadata": {
    "pmid": "29580149",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper reports a novel pathogenic BRCA2 mutation (c.4211C>G, p.Ser1404Ter) in a patient with prostate cancer, along with additional benign polymorphisms."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4211C>G",
      "protein_notation": "p.Ser1404Ter",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "46-year-old Chinese male",
        "phenotype": "prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 46,
          "age_at_onset": null,
          "age_at_diagnosis": 46,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "prostate adenocarcinoma (Gleason score 5+4)",
          "evidence_sentence": "In May 2011, a 46-year-old Chinese man with dysuria lasting for 6 months was referred to Daping Hospital of the Third Military Medical University."
        }
      ],
      "functional_data": {
        "summary": "The mutation results in a truncated protein, leading to loss of function.",
        "assays": [
          "immunohistochemistry",
          "western blot"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This is the first report of this specific BRCA2 mutation in a patient with prostate cancer.",
      "key_quotes": [
        "To our knowledge, we are the first to report the germline BRCA2 mutation c.4211C>G (p.Ser1404Ter) in prostate cancer."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7397T>C",
      "protein_notation": "p.Val2466Ala",
      "genomic_position": null,
      "clinical_significance": "benign",
      "patients": {
        "count": 1,
        "demographics": "46-year-old Chinese male",
        "phenotype": "prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 46,
          "age_at_onset": null,
          "age_at_diagnosis": 46,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "benign polymorphism",
          "evidence_sentence": "Analysis of peripheral blood also identified benign polymorphisms in BRCA2 (c.7397T>C, p.Val2466Ala)."
        }
      ],
      "functional_data": {
        "summary": "Identified as a benign polymorphism with no significant impact on protein function.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is considered benign and does not contribute to disease risk.",
      "key_quotes": [
        "Analysis of peripheral blood also identified benign polymorphisms in BRCA2 (c.7397T>C, p.Val2466Ala)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted from the main text."
  }
}